John Hoekman

Chief Technology & Development Officer

John served as our Chief Scientific Officer since July 2008 and is now Chief Technology and Development Officer. John has spent the last 14 years investigating intranasal drug delivery of therapeutics targeting the central nervous system. John co-founded Impel while attending graduate school at the University of Washington. He is the lead inventor of the POD technology and has made fundamental contributions to understanding intranasal drug delivery. John has spent the last 10 years working across all functions to grow Impel from a pre-clinical device focused company to a late-clinical stage pharmaceutical company. He holds a BS in Physics from the University of Minnesota and a Ph.D. in Pharmaceutics from the University of Washington.